Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Nov 20, 2014 (12 years ago)

Ginseng Kianpi Pil

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY

Recalling firm
One and Zen
Origin
NM, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0329-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other chemical / undeclared recalls from 2014

All chemical / undeclared recalls
Class I · High risk

Slim-K

Marketed Without An Approved NDA/ANDA: Product was found to contain sibutramine, desmethylsibutramine and phenolphthalein based on FDA sampling and analysis.

Terminated Chemical / undeclared Bethel Nutritional Consulting, Inc D-1207-2015
Class II · Moderate risk

MAYHEM capsules

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.

Terminated Chemical / undeclared Chaotic Labz D-0314-2015
Class I · High risk

Forever Beautiful INFINITY

Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain sibutramine and phenolphthalein

Terminated Chemical / undeclared REFA Enterprises, LLC D-0993-2015